EVENTIDE ASSET MANAGEMENT, LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001442891
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2025 · 268 positions · Total reported value $6.40B · Top-10 concentration 23.1% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 37.4% · 63 new · 55 cut · 18 exited
Active Share (vs S&P 500): 87.4% · vs QQQ: 88.9% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -8.4% · vs SPY -10.5% · Prev Value $7.48B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -2.0% · vs SPY -4.1% · Latest Value $7.12B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q4 2025 13F filing, EVENTIDE ASSET MANAGEMENT, LLC disclosed 268 equity positions with a combined reported value of $6.40B. The filing implies a diversified portfolio: its ten largest positions account for 23.1% of reported value. HoldingsHub classifies the profile as Mid / Diversified / Health Tilt / High Turnover.
The largest disclosed positions as of Q4 2025 were GH ($256.45M), XMTR ($174.72M), MIRM ($165.37M). By sector, the heaviest allocations are Health Care 39.7%, Technology 16.7%. Versus the prior quarter, allocation shifted toward Health Care (+8.0pp) and away from Financials (-0.7pp), Other (-2.0pp).
Versus the prior quarter, EVENTIDE ASSET MANAGEMENT, LLC opened 63 new positions, trimmed 55 and fully exited 18, a turnover rate of 37.4% of positions. The portfolio's overlap with the prior quarter was 75% of names.
The largest new positions opened in Q4 2025 were IONS ($45.49M), LBRT ($36.39M), APGE ($32.91M).
Of the 18 positions fully exited versus the prior quarter, the largest were VRNA ($72.66M), EVH ($53.25M), SLNO ($31.60M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q4 2025)
- IONS IONIS PHARMACEUTICALS INC · $45.49M
- LBRT LIBERTY ENERGY INC · $36.39M
- APGE APOGEE THERAPEUTICS INC · $32.91M
- DXCM DEXCOM INC · $31.48M
- MBX MBX BIOSCIENCES INC · $28.07M
- SION SIONNA THERAPEUTICS INC · $26.29M
- NRIX NURIX THERAPEUTICS INC · $24.62M
- ARWR ARROWHEAD PHARMACEUTICALS IN · $24.56M
Fully Exited (vs previous quarter)
- VRNA VERONA PHARMA ADR PLC ADR · prev qtr: $72.66M
- EVH EVOLENT HEALTH INC · prev qtr: $53.25M
- SLNO SOLENO THERAPEUTICS INC · prev qtr: $31.60M
- MTSR METSERA INC · prev qtr: $20.73M
- AKRO AKERO THERAPEUTICS INC · prev qtr: $20.67M
- PRCT PROCEPT BIOROBOTICS CORP · prev qtr: $16.72M
- ACAD ACADIA PHARMACEUTICALS INC · prev qtr: $12.28M
- RGEN REPLIGEN CORP · prev qtr: $10.39M
Insider Transactions (Form 4)
Latest EVENTIDE ASSET MANAGEMENT, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Eventide Asset Management, based in Boston, MA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 301 positions worth $7.48B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: BOSTON, MA, United States
- SEC registration: 801-69154 (status: Approved), registered 2008-05-21
- Regulatory AUM (Form ADV): $7.38B as of 2026-03-27
- Client mix (by RAUM): registered investment companies 98%, pension and profit-sharing plans 1%
- Manages 2 private funds
Portfolio Structure
- 301 positions · $7.48B reported value (Q2 2026)
- Top 10 holdings = 23.8% of reported value
- Largest position: GH (GUARDANT HEALTH INC) at 3.9%
- Average position size: $24.86M
Sector Tilt
- Health Care 35.1%
- Information Technology 22.3%
- Consumer Discretionary 13.1%
- (classified holdings cover 99% of value)
Quarterly Activity
- Q2 2026: 58 new, 143 added, 64 reduced, 35 exited
- 36 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
2.51M | $256.45M | 4.01% | Reduce | |
| 2 |
|
2.94M | $174.72M | 2.73% | Reduce | |
| 3 |
|
2.09M | $165.37M | 2.58% | Reduce | |
| 4 |
|
403.27K | $157.02M | 2.45% | Add | |
| 5 |
|
4.99M | $152.23M | 2.38% | Add | |
| 6 |
|
692.49K | $122.88M | 1.92% | Hold | |
| 7 |
|
187.12K | $122.37M | 1.91% | Reduce | |
| 8 |
|
669.09K | $114.64M | 1.79% | Reduce | |
| 9 |
|
2.43M | $107.09M | 1.67% | Reduce | |
| 10 |
|
571.23K | $104.20M | 1.63% | Reduce | |
| 11 |
|
121.22K | $101.94M | 1.59% | Reduce | |
| 12 |
|
610.64K | $95.81M | 1.50% | Add | |
| 13 |
|
480.55K | $88.71M | 1.39% | Add | |
| 14 |
|
2.49M | $88.31M | 1.38% | Hold | |
| 15 |
|
1.88M | $86.88M | 1.36% | Reduce | |
| 16 |
|
483.59K | $84.16M | 1.31% | Reduce | |
| 17 |
|
184.17K | $82.03M | 1.28% | Add | |
| 18 |
|
487.64K | $78.71M | 1.23% | Add | |
| 19 |
|
95.94K | $77.67M | 1.21% | Add | |
| 20 |
|
66.82K | $71.49M | 1.12% | Add | |
| 21 |
|
50.26K | $70.12M | 1.09% | Add | |
| 22 |
|
707.05K | $68.81M | 1.07% | Add | |
| 23 |
|
548.27K | $66.70M | 1.04% | Hold | |
| 24 |
|
673.08K | $62.33M | 0.97% | Add | |
| 25 |
|
68.37K | $62.02M | 0.97% | Add | |
| 26 |
|
427.05K | $61.54M | 0.96% | Reduce | |
| 27 |
|
383.09K | $61.28M | 0.96% | Add | |
| 28 |
|
45.28K | $55.22M | 0.86% | Reduce | |
| 29 |
|
155.98K | $55.11M | 0.86% | Hold | |
| 30 |
|
310.11K | $54.39M | 0.85% | Hold | |
| 31 |
|
527.60K | $54.29M | 0.85% | Hold | |
| 32 |
|
420.83K | $53.87M | 0.84% | Add | |
| 33 |
|
514.89K | $52.55M | 0.82% | Reduce | |
| 34 |
|
156.37K | $52.00M | 0.81% | Reduce | |
| 35 |
|
1.30M | $50.18M | 0.78% | Add | |
| 36 |
|
541.87K | $49.43M | 0.77% | Add | |
| 37 |
|
626.43K | $48.74M | 0.76% | Reduce | |
| 38 |
|
190.48K | $48.33M | 0.76% | Add | |
| 39 |
|
169.37K | $48.32M | 0.76% | Add | |
| 40 |
|
1.22M | $47.87M | 0.75% | Hold | |
| 41 |
|
793.16K | $47.68M | 0.74% | Reduce | |
| 42 |
|
1.13M | $47.34M | 0.74% | Add | |
| 43 |
|
394.72K | $47.27M | 0.74% | Add | |
| 44 |
|
124.60K | $46.73M | 0.73% | Add | |
| 45 |
|
1.41M | $46.69M | 0.73% | Hold | |
| 46 |
|
621.16K | $45.71M | 0.71% | Add | |
| 47 |
|
575.00K | $45.49M | 0.71% | New | |
| 48 |
|
239.28K | $44.69M | 0.70% | Hold | |
| 49 |
|
1.64M | $44.61M | 0.70% | Reduce | |
| 50 |
|
739.75K | $44.43M | 0.69% | Add | |
FAQ
What did EVENTIDE ASSET MANAGEMENT, LLC buy in 2025-Q4?
In its 2025-Q4 13F filing, EVENTIDE ASSET MANAGEMENT, LLC reported 268 equity positions worth $6.40B in aggregate; its largest disclosed positions were GH ($256.45M), XMTR ($174.72M), MIRM ($165.37M).
How large is EVENTIDE ASSET MANAGEMENT, LLC's portfolio?
EVENTIDE ASSET MANAGEMENT, LLC reported $6.40B of long equity holdings across 268 positions as of 2025-Q4. Top-10 holdings account for 23.1% of reported value.
What is EVENTIDE ASSET MANAGEMENT, LLC's investment style?
HoldingsHub classifies the portfolio as Mid / Diversified / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.